STAT+: Doctors Without Borders calls Gilead ‘unconsionable’ for refusing to sell HIV prevention drug to organization

Here is the synthesized article:

Can Diet and Medicine Converge to Improve Health Outcomes?

New research and developments in the medical field are pointing to a future where diet and medicine intersect to improve health outcomes, from mental health disorders to epilepsy and heart disease.

A recent study published in JAMA highlights the long-term risks of lead exposure, which can elevate blood pressure and harm blood vessel lining, increasing the risk of heart attack. Meanwhile, a breakthrough in identifying a genetic cause of childhood epilepsy is offering new hope for families affected by the condition.

What Happened

Doctors Without Borders has criticized Gilead Sciences for refusing to sell a limited supply of the HIV prevention drug lenacapavir to the organization. This development comes as the White House drafts legislative text for its drug pricing policy, sharing it with major pharmaceutical companies.

Why It Matters

The intersection of diet and medicine is becoming increasingly important in the treatment of mental health disorders. Shebani Sethi, a Stanford psychiatrist, is at the forefront of metabolic psychiatry, investigating the link between diet and serious mental health disorders.

> "The field of metabolic psychiatry is still in its early stages, but the potential for diet to influence mental health outcomes is vast." — Shebani Sethi

What Experts Say

Researchers from Manchester University NHS Foundation Trust and the University of Manchester have identified a neurodevelopmental disorder associated with seizures and severe developmental delay in children under one year old. The discovery is believed to be one of the most common genetic causes of childhood epilepsy.

Key Numbers

• 84: The number of cases worldwide of the recessive RNU2-2-related neurodevelopmental disorder.
• Millions: The estimated number of "carriers" of the faulty gene globally.
• 42%: The percentage of children with the disorder who experience seizures.

Key Facts

• Who: Doctors Without Borders, Gilead Sciences
• What: Refusal to sell HIV prevention drug lenacapavir
• When: After months of talks
• Where: Global
• Impact: Limited access to life-saving medication

What Comes Next

As research continues to uncover the links between diet and medicine, it is likely that we will see a shift in the way we approach health outcomes. The development of new treatments and the identification of genetic causes of diseases will play a crucial role in improving health outcomes for individuals around the world.

Background

The White House's drug pricing policy is expected to have significant implications for the pharmaceutical industry, with major companies already being consulted on the legislative text.

Key Takeaways

• Diet and medicine are converging to improve health outcomes
• New research is highlighting the long-term risks of lead exposure
• A breakthrough in identifying a genetic cause of childhood epilepsy is offering new hope for families
• The White House is drafting legislative text for its drug pricing policy